193 related articles for article (PubMed ID: 36996081)
1. Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids.
Ye Y; Lui VCH; Babu RO; Wu Z; Wu W; Chung PHY; Wong KKY; Wang B; Tam PKH
PLoS One; 2023; 18(3):e0283737. PubMed ID: 36996081
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of Hippo kinase signalling in human hepatic malignancies.
Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
[TBL] [Abstract][Full Text] [Related]
3. Specific recognition of an
White BS; Sindiri S; Hill V; Gasmi B; Nah S; Gartner JJ; Prickett TD; Li Y; Gurusamy D; Robbins P; Rosenberg SA; Leko V
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37045473
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma.
Graham RP; Barr Fritcher EG; Pestova E; Schulz J; Sitailo LA; Vasmatzis G; Murphy SJ; McWilliams RR; Hart SN; Halling KC; Roberts LR; Gores GJ; Couch FJ; Zhang L; Borad MJ; Kipp BR
Hum Pathol; 2014 Aug; 45(8):1630-8. PubMed ID: 24837095
[TBL] [Abstract][Full Text] [Related]
5. Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma.
Li F; Peiris MN; Donoghue DJ
Cytokine Growth Factor Rev; 2020 Apr; 52():56-67. PubMed ID: 31899106
[TBL] [Abstract][Full Text] [Related]
6. Congenital choledochal cysts in adults.
Visser BC; Suh I; Way LW; Kang SM
Arch Surg; 2004 Aug; 139(8):855-60; discussion 860-2. PubMed ID: 15302695
[TBL] [Abstract][Full Text] [Related]
7. Chimeric transcripts observed in non-canonical FGFR2 fusions with partner genes' breakpoint located in intergenic region in intrahepatic cholangiocarcinoma.
Yin L; Han Z; Feng M; Wang J; Xie Z; Yu W; Fu X; Shen N; Wang X; Duan A; Zhang Y; Ma J
Cancer Genet; 2022 Aug; 266-267():39-43. PubMed ID: 35749865
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes after hepaticojejunostomy for choledochal cyst: a 10- to 27-year follow-up.
Ono S; Fumino S; Shimadera S; Iwai N
J Pediatr Surg; 2010 Feb; 45(2):376-8. PubMed ID: 20152355
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
Fang M; Zhou Y; Li Z; Li X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):1-7. PubMed ID: 38158696
[TBL] [Abstract][Full Text] [Related]
11. De novo somatic mutations and KRAS amplification are associated with cholangiocarcinoma in a patient with a history of choledochal cyst.
Schwab ME; Song H; Mattis A; Phelps A; Vu LT; Huang FW; Nijagal A
J Pediatr Surg; 2020 Dec; 55(12):2657-2661. PubMed ID: 32295706
[TBL] [Abstract][Full Text] [Related]
12. The risk of carcinogenesis in congenital choledochal cyst patients: an analysis of 214 cases.
He XD; Wang L; Liu W; Liu Q; Qu Q; Li BL; Hong T
Ann Hepatol; 2014; 13(6):819-26. PubMed ID: 25332269
[TBL] [Abstract][Full Text] [Related]
13. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.
Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS
Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480
[TBL] [Abstract][Full Text] [Related]
14. Choledochal cyst with carcinoma of the intrahepatic bile ducts and pancreatic ducts.
DEXTER D
Br J Cancer; 1957 Mar; 11(1):18-25. PubMed ID: 13436692
[No Abstract] [Full Text] [Related]
15. Wnt-TCF7-SOX9 axis promotes cholangiocarcinoma proliferation and pemigatinib resistance in a FGF7-FGFR2 autocrine pathway.
Liu Z; Liu J; Chen T; Wang Y; Shi A; Li K; Li X; Qiu B; Zheng L; Zhao L; Shu L; Lian S; Huang S; Zhang Z; Xu Y
Oncogene; 2022 May; 41(20):2885-2896. PubMed ID: 35428876
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Choledochal Cyst: Insights from Genomics and Transcriptomics.
Ye Y; Lui VCH; Tam PKH
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741793
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
18. Gatekeeper Mutations and Intratumoral Heterogeneity in
Smyth EC; Babina IS; Turner NC
Cancer Discov; 2017 Mar; 7(3):248-249. PubMed ID: 28264865
[TBL] [Abstract][Full Text] [Related]
19. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Sia D; Villanueva A; Friedman SL; Llovet JM
Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
[TBL] [Abstract][Full Text] [Related]
20. Impact of FGFR2 gene fusions on survival of patients with intrahepatic cholangiocarcinoma following curative intent resection.
Buckarma E; De La Cruz G; Truty M; Nagorney D; Cleary S; Kendrick M; Borad M; Graham RP; Gores G; Smoot R
HPB (Oxford); 2022 Oct; 24(10):1748-1756. PubMed ID: 35718679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
